BioCatalyst

Neflamapimod — catalyst calendar

2 verified catalyst event(s) referencing Neflamapimod, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 26d
ESTIMATED
 READOUT
Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia
Phase 2 · Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
 EIP Pharma Inc Neflamapimod ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
2026-09-30
in 2mo
ESTIMATED
 READOUT
A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recover
Phase 2 · Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke
 EIP Pharma Inc Neflamapimod ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.